H2020FP7HORIZON
Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 25
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 8,125,902
- Active
- 2009 to 2025
Projects
25 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EUmetriosisEUmetriosis: Transforming endometriosis care in Europe: an integrated approach to enhance understanding, diagnosis, tailored management and patient empowerment | HORIZON | 2025 | Participant | EUR 794,287 |
| VIROMARKERSVirus related biomarkers to improve management of chronic conditions | HORIZON | 2025 | Participant | EUR 108,125 |
| GENIALUnderstanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma | HORIZON | 2023 | Participant | EUR 195,537 |
| ORTHO-ALLO-UNIONORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non-union (ORTHO-ALLO-UNION). | HORIZON | 2023 | Participant | EUR 711,922 |
| INNOVATIONIon channels in erythrocytes: A novel understanding from regulation of erythropoiesis and physiological function to diagnostic measures and therapeutic concepts | HORIZON | 2023 | Participant | EUR 259,438 |
| END-VOCENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC | HORIZON | 2022 | Participant | EUR 432,115 |
| D-SOLVEUnderstanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D | HORIZON | 2022 | Participant | EUR 508,750 |
| REVEALNeuronal microscopy for cell behavioural examination and manipulation | H2020 | 2021 | Participant | EUR 508,750 |
| IP-cure-BImmune profiling to guide host-directed interventions to cure HBV infections | H2020 | 2020 | Participant | EUR 198,538 |
| 3TRIdentification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | H2020 | 2019 | Participant | EUR 1,016,200 |
| c4cconect4children (COllaborative Network for European Clinical Trials For Children) | H2020 | 2018 | Third party | Not stated |
| CROSS-NEURODTransferring autonomous and non autonomous cell degeneration 3D models between EU and USA for development of effective therapies for neurodegenerative diseases (ND) | H2020 | 2018 | Participant | EUR 135,000 |
| MoveCareMultiple-actOrs Virtual Empathic CARgiver for the Elder | H2020 | 2017 | Participant | EUR 351,888 |
| ORTHOUNIONORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs | H2020 | 2017 | Participant | EUR 420,950 |
| MY-ATRIAMultidisciplinarY training network for ATrial fibRillation monItoring, treAtment and progression | H2020 | 2017 | Partner | EUR 0 |
| LSFM4LIFEProduction and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of type 1 diabetes | H2020 | 2016 | Participant | EUR 895,000 |
| MAST4HEALTHMastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). | H2020 | 2016 | Participant | EUR 9,000 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Participant | EUR 44,563 |
| PRECISESADSMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases | FP7 | 2014 | Participant | EUR 388,612 |
| COMBACTE-NETCombatting Bacterial Resistance in Europe | FP7 | 2013 | Participant | EUR 57,934 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.